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Wednesday, February 29, 2012 605aconsisting of a phospholipid (dioleoylphosphatidylcholine), cholesterol and di-
acylglycerol in a 50:50:3 mol ratio. In this protein-free system, fusion occurs
just by thermal fluctuations, above 60C. Under our conditions cholesterol is
essential to produce vesicle aggregation, but fusion is only observed when
small amounts of diacylglycerol are added. Vesicle fusion occurs only under
conditions when X-ray diffraction and cryo-transmission electron microscopy
of the lipid mixtures used in vesicle preparation show inverted lipid phase for-
mation (hexagonal and cubic).
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We have previously shown that DNA-lipid conjugates can be used to mediate
membrane fusion between small vesicles and also to construct membrane archi-
tectures, such as a DNA-tethered lipid bilayer patch which is distanced from
a glass coverslip by 8 nm long DNA duplex tethers. We currently employ these
bilayer patches in a model vesicle fusion system, studying the fusion (both
lipid-mixing and content-mixing) of small vesicles to the bilayer patches,
where fusion is mediated by complementary DNA-lipid partners in a geometry
similar to that of SNARE-mediated membrane fusion. This model system al-
lows us to quantitatively describe important aspects of membrane fusion,
such as the dependence of fusion
on DNA-lipid concentration, the
numbers of DNA-duplexes in-
volved in the fusion process, the
role of proximity and membrane
curvature on the fusion reaction.
We have also developed a kinetic
model describing the distribution
of docking-to-fusion wait times
and find that these wait times are
exponentially distributed, implying
a stochastic process which initiates
fusion. Insights into the biological
membrane fusion process are discussed.
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Influenza viruses have hundreds of hemagglutinin (HA) protein trimers embed-
ded in their phospholipid envelope. The HA protein is the lynchpin in the first
stage of influenza infection, first by facilitating binding and internalization into
target host cells and then by mediating fusion with the membrane of late endo-
somes. Recently, antibodies capable of neutralizing both group 1 and group 2
influenza A viruses have been described [Science,v324,p246,2009; Scien-
ce,v333,p843,2011]. These broadly neutralizing HA stem-binding antibodies
appear to act by blocking the HA conformational change necessary for fusion.
Here, we have visualized the interplay between a virus and antibodies during
neutralization using our recently developed single-particle fusion assay
[PNAS,v105(40),p15382,2008]. To this end, antibodies and infectious viral
particles were fluorescently labeled and incubated together. Viruses were
then bound to sialic acid decorated proteins incorporated into a planar, sup-
ported phospholipid bilayer and fusion induced by addition of an acidic buffer.
Using TIRF microscopy, individual hemifusion events were observed as the
rapid release of lipophilic dye from the viral membrane into the target bilayer.
This novel approach allows us to directly link the action of individual
HA-binding antibodies to viral fusion events, providing new insight into the
mechanism and molecular stoichiometry involved in fusion and neutralization -
information obfuscated in traditional cell-cell and bulk fusion assays. We see
a concentration dependent effect of inhibiting antibodies on the time it takes
for viruses to undergo hemifusion as well as on the total number of hemifusion
events. Furthermore, we can correlate the fluorescence intensity per virion to
the number of bound antibodies and thereby directly measure the number of
HA molecules involved in fusion. More to the point, our results have explicit
implications for the model of bilayer fusion arising from the coordinated efforts
of multiple hemagglutinins.3077-Plat
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The fusion of lipid membranes is ubiquitous in living organisms and allows the
transfer of membrane-impermeable molecules across the cell membrane and
different cell compartments. With the aim to systematically investigate mem-
brane fusion, we developed an advanced microfluidic device that facilitates
the close contact positioning of single cells and small unilamellar vesicles
(SUVs) and enables chemically induced fusion. The SUVs were immobilized
on discrete, micro contact printed spots on a glass surface. For vesicle immo-
bilization, we used biotin-PEG-cholesterol bound to immobilized avidin. Sup-
ply of the SUVs at low flow rates and incubation times of a few minutes enabled
efficient immobilization of the SUVs on the designated areas due to the inser-
tion of cholesterol into the lipid membrane. The patterned glass was covered by
a microfluidic device made of poly(dimethylsiloxane)(PDMS) that contained
the micro-channels for fluid supply and an integrated array of one hundred geo-
metric hurdles to trap individual cells. We studied the fusion of cells that are
trapped just above the immobilized SUVs by using total internal reflection fluo-
rescence microscopy and wide field fluorescence microscopy. In preliminary
experiments, the pH-induced fusions of suspension cells (U937) to SUVs pre-
pared from anionic and fusogenic phospholipids (DOPG and DOPE) were in-
vestigated. A fluorescence dequenching assay with two fluorophores (R18 and
HPTS) was employed to visualize, in real time, the fusion of cell and liposome
membranes and the release of the liposome’s enclosed fluids into the cytosol.
The novel platform will expand our knowledge of essential cellular processes.
Moreover, it facilitates screening of optimal fusion parameters and hence,
could improve the typically low efficiency of cell lipofection to deliver DNA
and other biomolecules into the cytosol. This would ultimately lead to novel
therapeutic strategies, e.g. against cancer.Platform: Membrane Transporters &
Exchangers II
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Recently we determined the first crystal structure of a member of the Proton
dependent Oligopeptide Transporter (POT) family, PepTSo, a prokaryotic ho-
mologue of the mammalian PepT1 and PepT2 proteins. PepT1 and PepT2 are
responsible for the uptake and re-absorption of dietary peptides and have a di-
rect effect on the oral bioavailability of important drug families. POT family
transporters belong to the Major Facilitator Superfamily (MFS) of secondary
active transport proteins and contain between 12 and 14 transmembrane heli-
ces. The structure of PepTSo revealed a ligand bound occluded state that
was noticeably asymmetric between the two canonical N- and C-terminal six
helical bundles present in MFS members. To gain further insight into the trans-
port mechanism of the POT family we have determined the structure of a second
member to 3.3 Angstrom resolution. Compared to PepTSo, this second struc-
ture reveals an essentially symmetric inward open conformation. Here we pres-
ent the analysis of this structure and show that using previously identified
inverted topology repeats present within the MFS fold we can create a model
for the currently missing outward open conformation. We further provide ex-
perimental evidence for the outward open model using double electron electron
resonance (DEER) measurements. These two crystal structures, combined with
the repeat swapped model, essentially describe the basic set of conformations
required for the alternating access model of transport within this pharmaceuti-
cally important family of MFS transporters.
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Glycerol-3-phosphate transporter (GlpT) is a member of major facilitator su-
perfamily (MFS), the largest family of secondary transporters. Similar to other
transporters, GlpT is believed to function using an ‘‘alternating-access’’ mech-
anism during which it undergoes large conformational changes. The only
available structure of GlpT is in the apo inward-facing (IF) state. In our earlier
work using equilibrium molecular dynamics (MD) simulations, the binding
site of GlpT was characterized and the initial substrate-induced closing on
